Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene.

Human hematopoietic stem cells remain one of the most promising target cells for gene therapeutic approaches to treat malignant and nonmalignant diseases. To rapidly characterize transduced cells and to isolate these from residual nontransduced, but biologically equivalent, cells, we have used a Moloney murine leukemia virus (Mo-MuLV)-based retroviral vector containing the intracytoplasmatically truncated human low-affinity nerve growth factor receptor (deltaLNGFR) cDNA as a marker gene. Supernatant transduction of CD34+ cells (mean purity 97%) in fibronectin-coated tissue culture flasks resulted in 5.5-45% (mean 26%) transduced cells expressing deltaLNGFR (LNGFR+ cells). After transduction, more than 65% of the transduced cells remained CD34+. Compared with control (mock- and nontransduced) CD34+ cells, transduction did not decrease the cloning efficiency of CD34+ cells. Immunomagnetic selection of the transduced cells with a monoclonal anti-LNGFR antibody resulted in >90% LNGFR+ cells. Further phenotypic characterization of these highly enriched LNGFR+ cells indicated that the majority co-expressed the CD34 and CD38 antigens. These results show that transduced cells expressing an ectopic cell-surface protein can be rapidly and conveniently quantitated and characterized by fluorescence-activated cell sorting (FACS) analysis and fast and efficiently enriched by immunoadhesion using magnetic beads. The use of cell-surface reporters should facilitate optimization of methods of gene transfer into more primitive hematopoietic progenitors.

[1]  C. Bordignon,et al.  HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. , 1997, Science.

[2]  A. Nienhuis,et al.  Gene transfer into hematopoietic cells , 1997, Stem cells.

[3]  David A. Williams,et al.  Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy , 1996, Nature Medicine.

[4]  S. Hegewisch-Becker,et al.  High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. , 1996, Blood.

[5]  E. Gilboa,et al.  Cell–surface markers for assessing gene transfer into human hematopoietic cells , 1996, Nature Medicine.

[6]  E. Gilboa,et al.  High-efficiency retroviral vector mediated gene transfer into human peripheral blood CD4+ T lymphocytes. , 1996, Gene therapy.

[7]  David A. Williams,et al.  Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. , 1996, Blood.

[8]  G. Dranoff,et al.  A cell surface marker gene transferred with a retroviral vector into CD34+ cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus. , 1996, Blood.

[9]  V. V. van Beusechem,et al.  Cell cycle state, response to hemopoietic growth factors and retroviral vector-mediated transduction of human hemopoietic stem cells. , 1996, Gene therapy.

[10]  S. Karlsson,et al.  A bicistronic therapeutic retroviral vector enables sorting of transduced CD34+ cells and corrects the enzyme deficiency in cells from Gaucher patients. , 1996, Blood.

[11]  David A. Williams,et al.  Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells , 1996, Nature Medicine.

[12]  C. Eaves,et al.  Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. , 1996, Blood.

[13]  B. Chesebro,et al.  High-frequency cell surface expression of a foreign protein in murine hematopoietic stem cells using a new retroviral vector. , 1996, Blood.

[14]  S. Hegewisch-Becker,et al.  Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells , 1995, Journal of virology.

[15]  Evelina Mazzolari,et al.  Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA− Immunodeficient Patients , 1995, Science.

[16]  A. Bank,et al.  Preselection of transduced murine hematopoietic stem cell populations leads to increased long-term stability and expression of the human multiple drug resistance gene. , 1995, Blood.

[17]  S. Heimfeld,et al.  Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. , 1995, The New England journal of medicine.

[18]  D. Kohn,et al.  Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. , 1995, Blood.

[19]  P. Lansdorp,et al.  Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer. , 1994, Blood.

[20]  C. Verfaillie,et al.  Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. , 1994, Blood.

[21]  S. Goff,et al.  Transfer and expression of the human multiple drug resistance gene in human CD34+ cells. , 1994, Blood.

[22]  C. Bordignon,et al.  Peripheral Blood Lymphocytes as Target Cells of Retroviral Vector-Mediated Gene Transfer , 1994 .

[23]  David A. Williams,et al.  Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. , 1994, The Journal of clinical investigation.

[24]  A. Ho,et al.  High efficiency retroviral-mediated gene transduction into CD34+ cells purified from peripheral blood of breast cancer patients primed with chemotherapy and granulocyte-macrophage colony-stimulating factor. , 1994, Human gene therapy.

[25]  E. Poeschla,et al.  Progress towards gene therapy for HIV infection. , 1994, Gene therapy.

[26]  J. Ihle,et al.  Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients , 1993, The Lancet.

[27]  A. Miller,et al.  Human gene therapy comes of age , 1992, Nature.

[28]  M. Ogawa,et al.  Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. , 1992, Blood.

[29]  S. Karlsson,et al.  Treatment of genetic defects in hematopoietic cell function by gene transfer. , 1991, Blood.

[30]  I. Weissman,et al.  The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Tsuruo,et al.  Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  K. Cornetta,et al.  Safety issues related to retroviral-mediated gene transfer in humans. , 1991, Human gene therapy.

[33]  A. Miller,et al.  Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection , 1990, Molecular and cellular biology.

[34]  A. Miller,et al.  Progress toward human gene therapy. , 1990, Blood.

[35]  D. Kohn,et al.  Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. , 1990, Human gene therapy.

[36]  Miller Ad,et al.  Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .

[37]  W. Anderson,et al.  Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent , 1989, Journal of virology.

[38]  K. Miyazono,et al.  Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietin , 1989, Journal of cellular physiology.

[39]  S. Goff,et al.  Construction and use of a safe and efficient amphotropic packaging cell line. , 1988, Virology.

[40]  S. Goff,et al.  A safe packaging line for gene transfer: separating viral genes on two different plasmids , 1988, Journal of virology.

[41]  E. Gilboa,et al.  Transfer and expression of cloned genes using retroviral vectors , 1986 .